🔴 Inovio Pharmaceuticals is trading 13% down with no confirmed catalyst identified

Inovio Pharmaceuticals is trading at $0.88, down 12.88%, with no confirmed company-specific catalyst identified for the October 21 decline.

• The broad market and biotech sector were positive, so they do not explain the move.
• Inovio announced an $80,416,101 court judgment on October 20; that prior-day news does not establish the cause of the decline.
• The company discussed an upcoming INO-3107 FDA decision expected October 30; no retrieved report linked either item to the decline.